跳到正文
Science Translational Medicine· Wenyu Fu, Ronghan Liu, Jin Wo, Xin Liu, Shuya Wang, Wenhao Song, Haoran Zhu, Yazhou Cui, Yuehong Chen, Chao Wang, Lei Zhang, Ran Schwarzkopf, Irvin Oh, Daniel H. Wiznia, Guodong Sun, Chuan-ju Liu·· 7 天前精选AI 评分70

BIG2 双重抑制 TNF-α 与 IL-1β 信号改善小鼠和灵长类骨关节炎

Dual inhibition of TNF-α and IL-1β signaling through BIG2 ameliorates osteoarthritis in mouse and primate models

AI 导读

发表于 Science Translational Medicine 的研究显示,通过 BIG2 双重抑制 TNF-α 与 IL-1β 信号,可改善小鼠和灵长类模型的骨关节炎。研究在两种动物模型中验证了这一联合干预,但材料仅提供摘要,未给出样本量、具体效应量与统计结果。

原文摘要

出版方登记 · Crossref

Osteoarthritis (OA), a leading cause of disability, is characterized by chronic low-grade inflammation and metabolic dysregulation in chondrocytes. TNF-α and IL-1β are key inflammatory drivers in OA pathogenesis, but clinical trials targeting them individually have been unsuccessful, highlighting the potential need for dual-targeting strategies. By screening a US Food and Drug Administration–approved drug library, we identified dabigatran, a thrombin inhibitor, as a potent dual suppressor of TNF-α and IL-1β signaling that restored chondrocyte metabolism. In preclinical OA models, including both mice and cynomolgus macaques, dabigatran attenuated cartilage degeneration, alleviated pain, and improved joint function. To elucidate the molecular mechanisms, we performed biochemical copurification coupled with mass spectrometry, identifying brefeldin A–inhibited guanine nucleotide–exchange protein 2 (BIG2) as a previously unknown dabigatran-binding target. Mechanistically, dabigatran binds to BIG2, promoting BIG2-dependent TNFR1 release to dampen TNF-α signaling while enhancing BIG2-mediated IL-1R1 degradation through the autophagy-lysosome pathway to limit IL-1β effects. These findings establish BIG2-mediated receptor trafficking and membrane dynamics as a regulatory node that concurrently inhibits TNF-α and IL-1β signaling, suggesting this pathway as a potential therapeutic strategy for OA.

页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文

推荐理由

在两种动物模型中同时抑制 TNF-α 与 IL-1β 信号,为骨关节炎的联合靶向策略提供了可检验的体内依据。

来源:Science Translational Medicine · science.org